A Phase 1 Study of REGN6569, a GITR Mab, in Combination with Cemiplimab in Patients (pts) with Advanced Solid Tumor Malignancies: Initial Dose-Escalation Results.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2024)